Zacks: Brokerages Anticipate Motus GI Holdings Inc (MOTS) to Announce -$0.33 EPS

Analysts predict that Motus GI Holdings Inc (NASDAQ:MOTS) will announce earnings per share (EPS) of ($0.33) for the current quarter, according to Zacks. Zero analysts have made estimates for Motus GI’s earnings. The lowest EPS estimate is ($0.36) and the highest is ($0.27). The company is scheduled to report its next quarterly earnings results on Wednesday, March 27th.

According to Zacks, analysts expect that Motus GI will report full-year earnings of ($1.33) per share for the current fiscal year, with EPS estimates ranging from ($1.41) to ($1.17). For the next fiscal year, analysts expect that the company will report earnings of ($1.00) per share, with EPS estimates ranging from ($1.27) to ($0.71). Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Motus GI.

Motus GI (NASDAQ:MOTS) last announced its quarterly earnings data on Wednesday, November 14th. The company reported ($0.33) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.27) by ($0.06).

A number of research analysts have recently commented on the stock. Zacks Investment Research raised shares of Motus GI from a “hold” rating to a “buy” rating and set a $4.50 price objective for the company in a research report on Tuesday. Oppenheimer set a $10.00 price objective on shares of Motus GI and gave the company a “buy” rating in a research report on Monday, November 26th. Seven analysts have rated the stock with a buy rating, Motus GI presently has an average rating of “Buy” and an average price target of $9.50.

Shares of MOTS opened at $4.18 on Thursday. The stock has a market cap of $65.58 million and a PE ratio of -3.27. Motus GI has a 52 week low of $2.34 and a 52 week high of $10.66.

In other Motus GI news, CEO Timothy P. Moran purchased 15,000 shares of the company’s stock in a transaction that occurred on Monday, November 19th. The stock was purchased at an average price of $3.48 per share, with a total value of $52,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gary E. Jacobs purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, December 24th. The stock was acquired at an average cost of $2.70 per share, with a total value of $27,000.00. The disclosure for this purchase can be found here. Insiders purchased 55,600 shares of company stock valued at $167,358 in the last three months.

A number of large investors have recently bought and sold shares of the stock. Private Advisor Group LLC acquired a new stake in shares of Motus GI during the third quarter worth approximately $105,000. Renaissance Technologies LLC acquired a new stake in shares of Motus GI during the third quarter worth approximately $139,000. Eaton Vance Management acquired a new stake in shares of Motus GI during the third quarter worth approximately $204,000. Finally, Lombard Odier Asset Management USA Corp increased its holdings in shares of Motus GI by 78.6% during the third quarter. Lombard Odier Asset Management USA Corp now owns 125,000 shares of the company’s stock worth $638,000 after buying an additional 55,000 shares in the last quarter. 22.17% of the stock is owned by hedge funds and other institutional investors.

About Motus GI

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Featured Story: Is the QQQ ETF safe?

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply